Roche Holding AG (RHHBY)
32.18
-0.46
(-1.41%)
USD |
OTCM |
Mar 18, 16:00
Roche Net Income (TTM): 12.86B for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 12.86B |
June 30, 2023 | 11.98B |
December 31, 2022 | 12.88B |
June 30, 2022 | 15.49B |
December 31, 2021 | 15.21B |
June 30, 2021 | 15.45B |
December 31, 2020 | 15.26B |
June 30, 2020 | 13.31B |
December 31, 2019 | 13.52B |
June 30, 2019 | 11.80B |
December 31, 2018 | 10.62B |
June 30, 2018 | 10.62B |
December 31, 2017 | 8.755B |
June 30, 2017 | 9.754B |
December 31, 2016 | 9.733B |
June 30, 2016 | 9.280B |
December 31, 2015 | 9.211B |
June 30, 2015 | 9.408B |
Date | Value |
---|---|
December 31, 2014 | 10.16B |
June 30, 2014 | 12.01B |
December 31, 2013 | 12.09B |
June 30, 2013 | 11.92B |
December 31, 2012 | 10.10B |
June 30, 2012 | 9.080B |
December 31, 2011 | 10.52B |
June 30, 2011 | 9.210B |
December 31, 2010 | 8.218B |
June 30, 2010 | 9.156B |
December 31, 2009 | 7.348B |
June 30, 2009 | 6.716B |
December 31, 2008 | 8.263B |
June 30, 2008 | 8.902B |
December 31, 2007 | 8.250B |
June 30, 2007 | 7.190B |
December 31, 2006 | 6.363B |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
11.80B
Minimum
Jun 2019
15.49B
Maximum
Jun 2022
13.78B
Average
13.42B
Median
Net Income (TTM) Benchmarks
Novartis AG | 14.85B |
Pfizer Inc | 2.119B |
Gilead Sciences Inc | 5.664B |
Eli Lilly and Co | 5.240B |
CRISPR Therapeutics AG | -153.61M |